Overview

A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the pharmacodynamics of ocular blood flow measurements with multiple drop unoprostone isopropyl administration versus placebo in subjects with dry age-related macular degeneration (AMD).

Phase:

Phase 2

Details

Lead Sponsor:

Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Collaborator:

Sucampo Pharmaceuticals, Inc.

Treatments:

Dinoprost
Isopropyl unoprostone